Skip to main content

Advertisement

SpringerLink
Log in

Hotline update of clinical trials and registries presented at the ACC and SCAI-ACCi2 meeting 2008 in Chicago

  • CLINICAL TRIAL UPDATES AND HOTLINE SESSIONS
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

This article summarizes the results of a number of new clinical trials, registries and meta-analyses in the field of cardiovascular medicine. Key presentations made at the annual meeting of the American College of Cardiology (ACC), held in Chicago, IL, USA from 29 March till first April 2008 are reported. The ACC meeting was accompanied by the SCAI (Society for Cardiovascular and Angiographic Interventions) Annual Scientific Sessions in Partnership with ACC i2 Summit. The data were presented by leading experts in the field with relevant positions in the trials, registries or meta-analyses. These comprehensive summaries should provide the readers with the most recent data on diagnostic and therapeutic developments in cardiovascular medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Beckett NS, Peters R, Fletcher AE et al; HYVET Study Group (2008) Treatment of hypertension in patients 80 years of age or older. N Engl J Med 358:1887–1898

    Google Scholar 

  2. Biondi-Zoccai GG, Lotrionte M, Moretti C, Meliga E, Agostoni P, Valgimigli M, Migliorini A, Antoniucci D, Carrié D, Sangiorgi G, Chieffo A, Colombo A, Price MJ, Teirstein PS, Christiansen EH, Abbate A, Testa L, Gunn JP, Burzotta F, Laudito A, Trevi GP, Sheiban I (2008) A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease. Am Heart J 155(2):274–283 (Epub 2007 Nov 26 review)

    Article  PubMed  Google Scholar 

  3. Bulpitt CJ, Beckett NS, Cooke J et al (2003) Results of the pilot study for the hypertension in the Very Elderly Trial. J Hypertens 21:2409–2417

    Article  PubMed  CAS  Google Scholar 

  4. Cantor WJ, Fitchett D, Borgundvaag B et al (2008) For the TRANSFER-AMI investigators. Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI). In: American College of Cardiology Scientific Sessions/i2 Summit-SCAI annual meeting. Late breaking clinical trials. Chicago, 29 March–1 April

  5. Chobanian AV, Bakris GL, Black HR et al (2003) Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42:1206–1252

    Article  PubMed  CAS  Google Scholar 

  6. DiSciascio G, Patti G, Colonna G et al (2008) Clopidogrel reloading before percutaneous coronary intervention improves outcome in patients with acute coronary syndromes receiving chronic clopidogrel therapy. Results of the antiplatelet therapy for reduction of myocardial damage during angioplasty-RELOAD (ARMYDA-RELOAD) randomized trial. In: American College of Cardiology Scientific Sessions/i2 Summit-SCAI annual meeting. Late breaking clinical trials. Chicago, 29 March–1 April

  7. Dormandy JA, Charbonnel B, Eckland DJA et al (2005) for the PROACTIVE Investigators. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial macroVascular Events): a randomized controlled trial. Lancet 366:1279–1289

    Article  PubMed  CAS  Google Scholar 

  8. Friedrich EB, Teo KK, Böhm M (2006) ACE inhibition in secondary prevention: are the results controversial? Clin Res Cardiol 95:61–67

    Article  PubMed  CAS  Google Scholar 

  9. Gueyffier F, Bulpitt C, Boissel JP et al (1999) Antihypertensive drugs in very old people: a subgroup meta-analysis of randomized controlled trials. INDANA Group 1. Lancet 353:793–796

    Article  PubMed  CAS  Google Scholar 

  10. Jamerson KA, Weber MA, Bakris GL, Dahlöf B, Pitt B, Velazquez E, on behalf of the ACCOMPLISH Investigators (2008) Avoiding cardiovascular events through combination therapy in patients living with systolic hypertension. American College of Cardiology Scientific Sessions. Chicago, 31 March

  11. Kastelein JJ, Akdim F, Stroes Es et al (2008) For the ENHANCE investigators. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 358:1431–1443

    Article  PubMed  CAS  Google Scholar 

  12. Kastrati A, Neumann FJ, Mehilli J et al (2008) A randomized, double-blind, active-controlled, multi-center trial (ISAR-REACT 3) of bivalirudin versus unfractionated heparin in troponin-negative patients undergoing percutaneous coronary interventions after pre-treatment with 600 mg of clopidogrel. In: American College of Cardiology Scientific Sessions/i2 Summit-SCAI annual meeting. Late breaking clinical trials. Chicago, 29 March–1 April

  13. Mancia G, de Backer G, Dominiczak A et al (2007) For the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Guidelines for the management of arterial hypertension. Eur Heart J 28:1462–1536

    PubMed  Google Scholar 

  14. Mehilli J, Kastrati A, Huber K et al (2008) Pretreatment with a high loading dose of clopidogrel and value of abciximab during primary coronary intervention in patients with acute myocardial infarction. Results of the randomized BRAVE-3 trial. In: American College of Cardiology Scientific Sessions/i2 Summit-SCAI annual meeting. Late breaking clinical trials. Chicago, 29 March–1 April

  15. Nissen SE, Nicholls SJ, Wolski K et al (2008) For the PERISCOPE investigators. Comparison of pioglitazone vs. glimepiride on progression of coronary atherosclerosis in pa-tients with type 2 diabetes. JAMA 299:1561–1573

    Article  PubMed  CAS  Google Scholar 

  16. Nissen SE, Nicholls SJ, Wolski K et al (2008) For the STRADIVARIUS investigators. Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease. The STRADIVARIUS randomized controlled trial JAMA 299:1547–1560

    Article  PubMed  CAS  Google Scholar 

  17. Scheller B, Hehrlein C, Bocksch W, Rutsch et al (2006) Treatment of in-stent restenosis with a paclitaxel-coated balloon catheter. New Engl J Med 355:2113–2124 (Epub 2006 Nov 13)

  18. Scheller B, Hennen B, Hammer B, Walle J, Hofer C, Hilpert V, Winter H, Nickenig G, Böhm M, for the SIAM III Study Group (2003) Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction J Am Coll Cardiol 42:634–641

    Article  PubMed  Google Scholar 

  19. Serruys PW (2008) On behalf of the SPIRIT II Investigators. SPIRIT II study: a clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions. In: American College of Cardiology Scientific Sessions/i2 Summit-SCAI annual meeting. Late breaking clinical trials. Chicago, 29 March–1 April

  20. Seung KB, Park DW, Kim YH et al (2008) Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med 358:1781–1792

    Google Scholar 

  21. Staels B, Fruchart JC (2005) Therapeutic roles of peroxisome proliferators-activated receptor agonists. Diabetes 54:2460–2470

    Article  PubMed  CAS  Google Scholar 

  22. Tepe G, Zeller T, Albrecht T et al (2008) Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. New Engl J Med 358:689–699

    Article  PubMed  CAS  Google Scholar 

  23. The ONTARGET investigators (2008) Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 358:1547–1559

    Article  Google Scholar 

  24. Unverdorben M, Degenhardt R, Vallbracht C et al (2008) Paclitaxel-eluting devices: randomized comparison of the SeQuent® please balloon catheter versus the Taxus® stent in the treatment of in-stent-restenosis—12-month follow-up of the PEPCAD II ISR study. In: American College of Cardiology Scientific Sessions/i2 Summit-SCAI annual meeting. Late breaking clinical trials. Chicago, 29 March–1 April

  25. Wessely R, Koppara T, Kastrati A et al (2008) Randomized clinical trial to compare the nephrotoxic effects of iso-osmolar versus low-osmolar contrast medium in patients with impaired renal function undergoing percutaneous coronary intervention: the COntrast Media and NephroToxicity Following Coronary Revascularization by AngioplaSTy (CONTRAST) study. In: American College of Cardiology Scientific Sessions/i2 Summit-SCAI Annual meeting. Late breaking clinical trials. Chicago, 29 March–1April

  26. Wiviott SD, Braunwald E, McCabe CH et al; TRITON-TIMI 38 Investigators (2008) Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial. Lancet 371:1353–1363

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Innere Medizin III, Kardiologie, Angiologie, und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Kirrberger Straße, 66421, Homburg/Saar, Germany

    Yvonne P. Clever, Stephan Rosenkranz, Michael Böhm & Bruno Scheller

  2. Klinik für Innere Medizin III, Universität zu Köln, Joseph-Stelzmann-Str. 9, 50924, Cologne, Germany

    Stephan Rosenkranz

Authors
  1. Yvonne P. Clever
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephan Rosenkranz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael Böhm
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bruno Scheller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yvonne P. Clever.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Clever, Y.P., Rosenkranz, S., Böhm, M. et al. Hotline update of clinical trials and registries presented at the ACC and SCAI-ACCi2 meeting 2008 in Chicago. Clin Res Cardiol 97, 409–417 (2008). https://doi.org/10.1007/s00392-008-0672-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-008-0672-7

Keywords

Search

Navigation